ID
40950
Descrição
The primary focus of this first time in human (FTIH) study was to evaluate the safety and tolerability of GSK1292263 and to estimate GSK1292263 pharmacokinetic (PK) parameters and pharmacodynamic (PD) effects in healthy volunteers. Subject: FTIH, oral, safety, tolerability, pharmacokinetics, glucose, pharmacodynamics, male, female, gastric emptying Indication Studied: Type 2 Diabetes Mellitus Study ID: 111596 Clinical Study ID: 111596 Study Title: A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00783549 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK1292263, Sitagliptin Trade Name: N/A Study Indication: Dyslipidaemias
Palavras-chave
Versões (2)
- 23/04/2020 23/04/2020 -
- 07/06/2020 07/06/2020 -
Titular dos direitos
GlaxoSmithKline
Transferido a
7 de junho de 2020
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin
ECG Abnormalities - Repeating Form, Logs/Repeats 8-RF-DF
- StudyEvent: ODM
Similar models
ECG Abnormalities - Repeating Form, Logs/Repeats 8-RF-DF
- StudyEvent: ODM
C1704258 (UMLS CUI-2)
C1704258 (UMLS CUI [1,2])
C0199556 (UMLS CUI [1,3])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0199556 (UMLS CUI-2)
C0205161 (UMLS CUI-3)
(Comment:en)
C0199556 (UMLS CUI [1,2])
C0205161 (UMLS CUI [1,3])
C0947611 (UMLS CUI [1,4])
C1704258 (UMLS CUI [1,2])
C0429072 (UMLS CUI [1,3])
C0232310 (UMLS CUI-2)
(Comment:en)
C0232308 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0522055 (UMLS CUI-2)
C0332437 (UMLS CUI-3)
(Comment:en)
C0332437 (UMLS CUI [1,2])
C0430456 (UMLS CUI [1,3])
C1704258 (UMLS CUI [1,4])
C0947611 (UMLS CUI [1,5])
C1704258 (UMLS CUI [1,2])
C0232217 (UMLS CUI [1,3])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0043202 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
C0232217 (UMLS CUI-2)
C0522055 (UMLS CUI-3)
(Comment:en)
C0232217 (UMLS CUI [1,2])
C0430456 (UMLS CUI [1,3])
C1704258 (UMLS CUI [1,4])
C0947611 (UMLS CUI [1,5])
C0947611 (UMLS CUI [1,6])
C1704258 (UMLS CUI [1,2])
C0027051 (UMLS CUI [1,3])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0027051 (UMLS CUI-2)
(Comment:en)
C0027051 (UMLS CUI [1,2])
C0947611 (UMLS CUI [1,3])
C1704258 (UMLS CUI [1,2])
C0948857 (UMLS CUI [2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0429059 (UMLS CUI-2)
(Comment:en)
C0948857 (UMLS CUI-2)
(Comment:en)
C0430456 (UMLS CUI [1,2])
C1704258 (UMLS CUI [1,3])
C0947611 (UMLS CUI [1,4])
C0205394 (UMLS CUI [2,1])
C0948857 (UMLS CUI [2,2])
C0947611 (UMLS CUI [2,3])
C1704258 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0947611 (UMLS CUI [1,4])
Sem comentários